High FRMD3 expression is prognostic for worse survival in rectal cancer patients treated with CCRT

Chen, TJ; Chou, CL; Tian, YF; Yeh, CF; Chan, TC; He, HL; Li, WS; Tsai, HH; Li, CF; Lai, HY

Li, CF; Lai, HY (corresponding author), Chi Mei Med Ctr, Dept Clin Pathol, 901 Chunghwa Rd, Tainan 710, Taiwan.; Li, CF; Lai, HY (corresponding author), Chi Mei Med Ctr, Dept Med Res, 901 Chunghwa Rd, Tainan, Taiwan.; Li, CF (corresponding author), Natl Inst Canc Res, Natl Hlth Res Inst, Tainan, Taiwan.; Li, CF (corresponding author), Chi Mei Med Ctr, Dept Pathol, Tainan, Taiwan.; Li, CF (corresponding author), Natl Sun Yat Sen Univ, Inst Precis Med, Kaohsiung, Taiwan.

INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2021; 26 (9): 1689

Abstract

Background Rectal cancer patients can conceivably obtain relief from neoadjuvant concurrent chemoradiotherapy (CCRT) for downstaging before resection,......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索